Topic
Cryoablation
39 Podcasts • 5 Cases • 3 Courses on BackTable
Hear how experienced physicians approach Cryoablation on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering patient selection, workup, and procedure technique. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.
Episode # 653 • 09 Jun 2026
Radiation Lobectomy Techniques & Downstaging for HCC
How can targeted liver radiation unlock surgical or transplant options for tough hepatocellular carcinoma (HCC) cases? In this episode of the BackTable 2026 HCC Creator Weekend™, host Dr. Kavi Krishnasamy is joined by interventional radiologists Dr. Beau Toskich and Dr. Chris Malone to explore how downstaging and radiation lobectomy with Y90 are creating new surgical and transplant opportunities for patients with limited future liver remnants. They discuss Y90’s role as a “test of time” for tumor biology, strategies to prevent post-hepatectomy liver failure, and the ongoing challenge of recurrence even after R0 resection in cirrhotic livers.
This podcast is supported by an educational grant from Sirtex and Boston Scientific.
More on Cryoablation
Loading recent podcasts…
Vascular & IR # 653
Jun 9, 2026
with Dr. Beau Toskich, Dr. Christopher Malone, Dr. Venkatesh Krishnasamy
How can targeted liver radiation unlock surgical or transplant options for tough hepatocellular carcinoma (HCC) cases?...
190+ listens
Vascular & IR # 649
May 27, 2026
with Dr. Nima Kokabi, Dr. Riad Salem, Dr. Zach Berman
Can the right dosimetry approach turn palliative Y90 into a curative therapy? In this episode of the BackTable 2026 HCC...
1,100+ listens
Vascular & IR # 639
Apr 30, 2026
with Dr. Christopher Malone, Dr. Kirema Garcia-Reyes, Dr. Venkatesh Krishnasamy
Why settle for “good enough” ablation margins when today’s tools can deliver more and decrease the risk of recurrence?...
40+ listens
Vascular & IR # 613
Feb 3, 2026
with Dr. Steven Huang, Dr. Michael Barraza
You’re about to biopsy a renal lesion; should you ablate at the same time? In this episode of the BackTable Podcast,...
1,900+ listens
Vascular & IR # 651
Jun 2, 2026
with Dr. Kirema Garcia-Reyes, Dr. Zach Berman, Dr. Nima Kokabi
What does it really take to run a high-volume Y90 program that is efficient, scalable, and patient-centered? In this...
1,000+ listens
Vascular & IR # 642
May 7, 2026
with Dr. Beau Toskich, Dr. Zach Berman, Dr. Venkatesh Krishnasamy
Complete pathologic necrosis (CPN) rates above 90%? This week’s BackTable episode from the 2026 HCC Creator Weekend™ is...
70+ listens
Tumor Board # 46
Feb 3, 2026
with Dr. William Moore, Dr. Daniel Sterman, Dr. Ben Cooper
Pulsed electric field (PEF) therapy is an emerging cancer treatment that utilizes short electrical pulses to disrupt...
550+ listens
Vascular & IR # 610
Jan 23, 2026
with Dr. Jamal AlKoteesh, Dr. Sabeen Dhand
Have you ever considered taking a sabbatical to practice Interventional Radiology in the Middle East? In this episode,...
1,800+ listens
VI Case
Jun 24, 2025
with Dr. Tyler Sandow, Dr. Nima Kokabi and Dr. Venkatesh Krishnasamy
VI Case
Nov 21, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Case
Nov 11, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
VI Case
Nov 21, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Case
Nov 11, 2025
with Dr. Alan Lee, Dr. Scott Oh, Dr. Robert Suh, Dr. Scott Genshaft and Dr. Venkatesh Krishnasamy
Tumor Board Course
2 CME/CE credits, 2.5 hours, 26 lessons
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.